As former Sentinel columnist George Diaz writes, Dan Jaworski is beating the odds and helping the fight against Alzheimer’s ...

A new bipartisan bill would end the coverage gap for dementia screening, allowing early diagnosis when treatments are most ...

People living with Alzheimer’s and dementia are especially vulnerable during winter weather. Impaired judgment and difficulty ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Dr. Thijssen offers a distinctive viewpoint on one of medicine’s critical issues: identifying Alzheimer’s disease early, ...

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

The drug is called NU-9, and a team from Northwestern University in the US tested it on mouse models of Alzheimer's disease.

Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

A new drug being developed by scientists at Northwestern University may offer an exciting way to slow down or prevent ...